Posted in | News | Petrochemicals

Total Inaugurate World's Largest Ethane Cracker

Total announces the inauguration of the world's largest olefin cracker based on ethane in Ras Laffan, Qatar. With a production capacity of 1.3 million tons of ethylene per year, the Ras Laffan Olefin Cracker (RLOC) will feed the new Qatofin polyethylene plant inaugurated in Mesaieed last November. Total Petrochemicals, through its participations in Qapco and Qatofin, joint ventures with Qatar Petroleum, holds 22.2% of RLOC. The other partners are Qatar Petroleum and Chevron Phillips Chemical Company.

Ras Laffan Olefin Cracker Copyright: RLOC

The ethane feedstock used in the Ras Laffan cracker comes from the North Field,a giant offshore gas field in which Total holds interests through the Dolphin and Qatargas I and II projects. The natural gas (methane) is treated for export in the liquefaction plants also based in Ras Laffan and the associated ethane produced at Dolphin will be valorized by the Ras Laffan cracker as raw material for the petrochemical industry.

Total Petrochemicals has a long record of successful partnerships with Qatar since the foundation of Qapco in 1974. "With the start-up last November of the Qatofin polyethylene plant and now with the Ras Laffan cracker, Total is further strengthening its partnership with the Qatari energy and petrochemical sector. These major projects are considerably enhancing our position in Petrochemicals, in particular in the growing markets in Asia and the Middle East", stated François Cornélis, Vice Chairman of the Executive Committee of Total and President Chemicals.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.